Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women

Gynecological Endocrinology

Volumn 20, Issue 2, 2005, Pages 64-67

  Inan, Ismet ^a   Kelekci, Sefa ^b,c   Yilmaz, Bülent ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Etlik Education and Research Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Beck's depression score; Hormone replacement therapy; Lipid profile; Mood; Perimenopause; Tibolone

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; TIBOLONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PARITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

DEPRESSIVE DISORDER; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NORPREGNENES; PERIMENOPAUSE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 18044363129     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590400020963     Document Type: Article

References (18)

1. Hay AG, Bancroft J, Johnstone EC. Affective symptoms in women attending a menopause clinic. Br J Psychiatry 1994; 164:513-516.
2. Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 1999;56:418-424.
3. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: a justification for further study. Am J Psychiatry 1994;148:844-852.
4. Kopera H, Utihan WH. Twenty five years of hormone replacement therapy. Maturitas 1990;12:159-319.
5. Veeninga AT, Kraimaat FW. A multifactorial approach to complaints during the climacteric. J Reprod Infant Psychol 1995;13:69-77.
6. Rymer J, Chapman MG, Fogelman I, Wilson PO. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 1994;18:127-133.
7. Genazzani AR, Petralgia F, Facchinetti F, Grasso A, Alessandrini G, Volpe A. Steroid replacement treatment increases β-endorphin and β lipoprotein levels in post menopausal women. Gynaecol Obstet Invest 1988;26:153-159.
8. Hisli N. A study on the validity of Beck depression inventory. Psikoloji Dergisi 1988;6:118-122.
9. Schmidt PJ, Lynette D, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183:414-420.
10. Tax L, Goorissen EM, Kicovic PM. Clinical profile of Org OD 14. Maturitas 1997;(1 Suppl):3-13.
11. Bukulmez O, Atakan AI, Gurdal H, Yarali H, Ulug B, Gurgan T. Short-term effects of three continuous hormone replacement therapy regimens on platelet tritiated imipramine binding and mood scores: a prospective randomized trial. Fertil Steril 2001;75:737-743.
12. Genazzani AR, Gambacciani M, Simoncini T, Schneider PGH. 'Controversial issues in climacteric medicine' series 3rd Pisa workshop 'HRT in climacteric and aging brain'. Pisa, Italy, 15-18 March 2003. Maturitas 2003;46:7-26.
13. Genazzani AR, Petraglia F, Facchinetti AD, Genazzani M, Bergamanashi A, Grasso A, Volpe A. Effects of Org OD 14 on pituitary and peripheral endorphin in castrated rats and in postmenopausal women. Maturitas 1987;(1 Suppl):35-58.
14. Kugaya A, Epperson CN, Zoghbi S, van Dyck CH, Hou Y, Fujita M, Staley JK, Garg PK, Seibyl JP, Innis RB. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 2003; 160:1522-1524.
15. Zweifel JE, O'Brain WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.
16. Egarter C, Huber J, Leikermoser R, Haidbauer R, Pusch H, Fischl F, Putz M. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas 1996;23:55-62.
17. Lobo RA, Bush T, Carr BR, Pickar JH. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 2001;76: 13-24.
18. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 2001;75:898-915.